Advanced Micro Devices R&D increased by 2.9% to $2.40B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.7%, from $1.73B to $2.40B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 29.9% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $659.00M | $765.00M | $811.00M | $1.06B | $1.30B | $1.28B | $1.37B | $1.41B | $1.44B | $1.51B | $1.51B | $1.53B | $1.58B | $1.64B | $1.71B | $1.73B | $1.89B | $2.14B | $2.33B | $2.40B |
| QoQ Change | — | +16.1% | +6.0% | +30.7% | +22.6% | -1.6% | +6.8% | +3.3% | +2.3% | +4.4% | +0.3% | +0.9% | +3.8% | +3.3% | +4.6% | +0.9% | +9.6% | +12.9% | +8.9% | +2.9% |
| YoY Change | — | — | — | — | +97.3% | +67.2% | +68.4% | +33.1% | +11.0% | +17.8% | +10.6% | +8.1% | +9.7% | +8.6% | +13.3% | +13.3% | +19.6% | +30.7% | +36.1% | +38.7% |